Together, EGFR, GRIN2B, GJA1, CAP2, MIF, POLR2A, PRKACA, GABARAP, TLN1 and PXN might be effective targets in T1D, but more experimental investigations and clinical trials are needed. This evidence concerns the gene PXN and type 1 diabetes mellitus.